|
TAS2R38 (taste receptor, type 2, member 38) |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
|
APOC1 (apolipoprotein C-I) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
DRD5 (Dopamine receptor D5) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
NCF1 (Neutrophil cytosolic factor 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
DUX4 (double homeobox 4) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
MCPH1 (microcephalin 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
|
TTR (transthyretin) |
MOCA Author |
Genetics |
Likely Difference |
|
AQP7 (aquaporin 7) |
Laura Dumas, James Sikela |
Genetics |
Likely Difference |
|
DUSP22 (Dual specificity phosphatase 22) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
OCLN (Occludin) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
KIR3DL1 (killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
MC1R (melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) ) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
TH (tyrosine hydroxylase) |
Landon Klein |
Genetics |
Relative Difference |
|
EDAR (ectodysplasin A receptor) |
Majesta O'Bleness |
Genetics |
Likely Difference |
|
E2F6 (E2F transcription factor 6) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
PDE4DIP (Phosphodiesterase 4D interacting protein) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
CASC5 (Cancer Susceptibility Candidate 5 ) |
Majesta O'Bleness |
Genetics |
Likely Difference |
|
NBPF15 (neuroblastoma breakpoint family, member 15) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
FCGR1A (Fc fragment of IgG, high affinity Ia, receptor (CD64)) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
PTPN20A (Protein tyrosine phosphatase, non-receptor type 20A) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SPANXB (SPANX family, member B) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
MHC Class I |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
|
SIGLEC14 (sialic acid binding Ig-like lectin 14) |
Ajit Varki |
Genetics |
Absolute Difference |
|
FRMPD2 (FERM and PDZ domain containing 2) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SERPINA13 (Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 13) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SPANXC (SPANX family, member C) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
APOE (apolipoprotein E) |
Caleb Finch |
Genetics |
Relative Difference |
|
MYH16 (myosin, heavy chain 16 pseudogene) |
Naruya Saitou |
Genetics |
Absolute Difference |
|
SIGLEC7 (sialic acid binding Ig-like lectin 7 ) |
Ajit Varki |
Genetics |
Likely Difference |
|
GLRA4 (Glycine receptor, alpha 4) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
RAB3IP (RAB3A interacting protein) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
AHI1 (Abelson Helper Integration Site 1 ) |
Majesta O'Bleness |
Genetics |
Likely Difference |
|
ASPM (asp (abnormal spindle) homolog, microcephaly associated) |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
|
PCDH11XY (protocadherin 11 X Y linked) |
Tim Crow, Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
SIGLEC16 (sialic acid binding Ig-like lectin 16) |
Ajit Varki |
Genetics |
Likely Difference |
|
ABCB10 (ATP-binding cassette, subfamily B (MDR/TAP) member 10) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
GRIN3A (Glutamate receptor, ionotropic, N-methyl-D-aspartate 3A) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
RGS6 (Regulator of G-protein signaling 6) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
OR4F17 (olfactory receptor, family 4, subfamily F, member 17) |
Majesta O'Bleness, James Sikela |
Genetics |
|
|
CASP12 (caspase-12 gene/pseudogene) |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
|
CCL3L1 (chemokine (C-C motif) ligand 3-like 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
PDYN (prodynorphin) |
Majesta O'Bleness, James Sikela |
Genetics |
Speculative Difference |
|
ARHGEF5 (Rho guanine nucleotide exchange factor (GEF) 5) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
GRIN3B (Glutamate receptor, ionotropic, N-methyl-D-aspartate 3B) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SERF1A (Small EDRK-rich factor 1A) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
TRGV10 (T cell receptor gamma variable 10) |
Majesta O'Bleness, James Sikela |
Genetics |
|
|
CMAH (cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminate monooxygenase) pseudogene) |
Ajit Varki |
Genetics |
Absolute Difference |
|
RLN (relaxin) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
C22orf45 (Chromosome 22 open reading frame 45) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
GTF2H2 (General transcription factor IIH, polypeptide 2, 44kDa) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SMN1 (Survival of motor neurone 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
HLA-DRB1*11 (major histocompatibility complex, class II, DR beta 1 allele 11 ) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
COX5A (cytochrome c oxidase subunit Va) |
Lawrence Grossman |
Genetics |
Relative Difference |
|
SIGLEC1 (sialic acid binding Ig-like lectin 1, sialoadhesin) |
Ajit Varki |
Genetics |
Likely Difference |
|
ABO (ABO blood group ) |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
|
AR (Androgen receptor) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
CDH12 (cadherin 12, type 2 (N-cadherin 2) ) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
GTF2IRD2 (GTF2I repeat domain containing 2) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SMN2 (Survival of motor neurone 2) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
C20orf203 (chromosome 20 open reading frame 203) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
SLC6A8 (solute carrier family 6 (neurotransmitter transporter, creatine), member 8) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SIGLEC11 (sialic acid binding Ig-like lectin 11) |
Ajit Varki |
Genetics |
Likely Difference |
|
HAR1 (human accelerated region 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
|
CDK5RAP2 (CDK5 regulatory subunit-associated protein 2) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
CHRFAM7A (CHRNA7 (cholinergic receptor, nicotinic, alpha 7) and FAM7A (family with sequence similarity 7A) fusion) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
HYDIN (Hydrocephalus inducing homolog) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
SRGAP2 (SLIT-ROBO Rho GTPase activating protein 2) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
|
S100A7 (S100 calcium binding protein A7) |
Majesta O'Bleness, James Sikela |
Genetics |
|
|
Androgen Metabolism in the Brain |
Camille Toarmino |
Endocrinology |
|
|
Thyroid Hormone Metabolism |
MOCA Author |
Endocrinology |
Likely Difference |
|
DHEA/DHEAS Circulating Levels |
MOCA Author |
Endocrinology |
Relative Difference |
|
Self-Medication (Zoopharmacognosy) |
Majesta O'Bleness |
Pharmacology |
Relative Difference |
|
Arsenic Detoxification |
MOCA Author |
Pharmacology |
Likely Difference |
|
Mind-Altering Drug Use |
Landon Klein |
Pharmacology |
Likely Difference |
|
Serum Cholesterol Level |
Caleb Finch |
Pathology |
Likely Difference |
|
Alzheimer's Disease Pathology (Neurofibrillary Tangles) |
Caleb Finch |
Pathology |
Absolute Difference |
|
Serum Alkaline Phosphatase Level |
MOCA Author |
Pathology |
Relative Difference |
|
Uterine Adenomyosis and Endometriosis |
Nissi Varki |
Pathology |
Relative Difference |
|
Neoplasm Types and Prevalence |
Nissi Varki |
Pathology |
Relative Difference |
|
Serum Uric Acid Level |
MOCA Author |
Pathology |
Relative Difference |
|
Rheumatoid Arthritis |
MOCA Author |
Pathology |
Relative Difference |
|
Atherosclerosis |
Nissi Varki |
Pathology |
Relative Difference |
|
Blood Group Antigen Types and Prevalence |
Leela Davies |
Pathology |
Relative Difference |
|
Erythrocyte Sedimentation Rate |
MOCA Author |
Pathology |
Relative Difference |
|
Age-Associated Osteoporosis |
MOCA Author |
Pathology |
Speculative Difference |
|
Major Basic Protein in Placenta and Eosinophils |
MOCA Author |
Pathology |
Likely Difference |
|
Gout |
Nissi Varki |
Pathology |
Speculative Difference |
|
Absolute Leukocyte Count |
MOCA Author |
Pathology |
Absolute Difference |
|
Hemochromatosis |
Nissi Varki |
Pathology |
Speculative Difference |
|
Absolute Lymphocyte Count |
Robert Thomas |
Pathology |
Absolute Difference |
|
Inflammatory Bowel Disease |
Nissi Varki |
Pathology |
Speculative Difference |
|
Absolute Neutrophil Count |
MOCA Author |
Pathology |
Absolute Difference |
|
Colonic Polyps |
Nissi Varki |
Pathology |
Relative Difference |
|
Diverticulosis |
Nissi Varki |
Pathology |
Absolute Difference |
|
Benign Prostatic Hyperplasia |
Nissi Varki |
Pathology |
Likely Difference |
|
Polycystic Ovarian Disease |
Nissi Varki |
Pathology |
Absolute Difference |
|
Sarcoidosis |
Nissi Varki |
Pathology |
Speculative Difference |
|
Systemic Lupus Erythematosus |
Nissi Varki |
Pathology |
Speculative Difference |
|
Serum Lp(a) Level |
MOCA Author |
Pathology |
Relative Difference |
|
Molar Morphology |
MOCA Author |
Dental Biology and Disease |
|
